HPV infection and cervial dysplasia in bone marrow transplant recipients

Not Applicable

Recruiting

• Conditions: Bone Marrow Transplant; Surgery - Other surgery

• Registration Number: ACTRN12605000645651
• Lead Sponsor: Melbourne Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Patients who are about to undergo bone marrow transplantation, either allogeneic or autologous; Patients expected to survive for the 3 year follow up period.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate impact of immunosuppression associated with bone marrow transplantation on cervical cytology and HPV infection[Over a 5 year period.]

Secondary Outcome Measures

Name	Time	Method
To assess the impact of conditioning regimens on cytology and the difference in outcome parameters between allogeneic and autologous transplant recipients.[Over a 5 year period.]